You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Novartis reveals vital Leqvio data

Novartis has announced new long-term data from its ORION-8 clinical trial. The study is a phase 3 open-label extension of the company’s ORION-9, ORION-10, ORION-11 and ORION-3 trials.